{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T22:58:34Z","timestamp":1762642714410,"version":"3.40.5"},"reference-count":28,"publisher":"Bentham Science Publishers Ltd.","issue":"3","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CRCEP"],"published-print":{"date-parts":[[2023,11]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Autosomal dominant polycystic kidney disease (ADPKD) may coexist with other genetic disorders, such as tuberous sclerosis, when deletion in TSC2\/PKD1 genes occurs. Recently, the effect of tolvaptan has been explored in ADPKD patients alone, but its safety and efficacy on TSC2\/PKD1 contiguous gene syndrome is unknown.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Case Presentation:<\/jats:title>\n<jats:p>This report describes the case of an asymptomatic patient with TSC2\/PKD1 contiguous gene syndrome that fulfills the imaging criteria for initiating the treatment with tolvaptan. After twelve months, the patient did not exhibit severe adverse effects and blood pressure control improved.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>In this TSC2\/PKD1 contiguous gene syndrome single case report, tolvaptan was safe and well-tolerated. More extensive experimental studies are needed to deeply understand the therapeutic implications of vasopressin V2-receptor inhibition in the TSC2\/PKD1 contiguous gene syndrome patients.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/2772432817666220517162012","type":"journal-article","created":{"date-parts":[[2022,5,19]],"date-time":"2022-05-19T05:57:34Z","timestamp":1652939854000},"page":"284-290","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["A Case Report of Tuberous Sclerosis and Autosomal Dominant Polycystic\nKidney Disease in the Era of Tolvaptan"],"prefix":"10.2174","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5999-225X","authenticated-orcid":true,"given":"Xavier E.","family":"Guerra-Torres","sequence":"first","affiliation":[{"name":"Nephrology Section, Hospital Universitario Principe de Asturias, Alcala de Henares, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"iv95","DOI":"10.1093\/ndt\/gfu186","volume":"29","author":"Ars E.","year":"2014","unstructured":"Ars E.; Bernis C.; Fraga G.; Spanish guidelines for the management of autosomal dominant polycystic kidney disease. Nephrol Dial Transplant 2014,29(Suppl. 4),iv95-iv105","journal-title":"Nephrol Dial Transplant"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/S0272-6386(83)80044-4","volume":"2","author":"Iglesias C.G.","year":"1983","unstructured":"Iglesias C.G.; Torres V.E.; Offord K.P.; Holley K.E.; Beard C.M.; Kurland L.T.; Epidemiology of adult polycystic kidney disease, Olmsted County, Minnesota: 1935-1980. Am J Kidney Dis 1983,2(6),630-639","journal-title":"Am J Kidney Dis"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/0092-8674(94)90137-6","volume":"77","year":"1994","unstructured":"The polycystic kidney disease 1 gene encodes a 14 kb transcript and lies within a duplicated region on chromosome 16. Cell 1994,77(6),881-894","journal-title":"Cell"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1038\/ng.2715","volume":"45","author":"Ma M.","year":"2013","unstructured":"Ma M.; Tian X.; Igarashi P.; Pazour G.J.; Somlo S.; Loss of cilia suppresses cyst growth in genetic models of autosomal dominant polycystic kidney disease. Nat Genet 2013,45(9),1004-1012","journal-title":"Nat Genet"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1016\/j.ajhg.2016.05.004","volume":"98","author":"Porath B","year":"2016","unstructured":"Porath B; Gainullin VG; Cornec-Le ; Mutations in GANAB, encoding the glucosidase IIand#945; subunit, cause autosomal-dominant polycystic kidney and liver disease. Am J Hum Genet 2016,98(6),1193-1207","journal-title":"Am J Hum Genet"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1126\/science.272.5266.1339","volume":"272","author":"Mochizuki T.","year":"1996","unstructured":"Mochizuki T.; Wu G.; Hayashi T.; PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein. Science 1996,272(5266),1339-1342","journal-title":"Science"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/S0140-6736(08)61279-9","volume":"372","author":"Curatolo P.","year":"2008","unstructured":"Curatolo P.; Bombardieri R.; Jozwiak S.; Tuberous sclerosis. Lancet 2008,372(9639),657-668","journal-title":"Lancet"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1590\/abd1806-4841.20186972","volume":"93","author":"Portocarrero L.K.L.","year":"2018","unstructured":"Portocarrero L.K.L.; Quental K.N.; Samorano L.P.; Oliveira Z.N.P.; Rivitti-Machado M.C.D.M.; Tuberous sclerosis complex: Review based on new diagnostic criteria. An Bras Dermatol 2018,93(3),323-331","journal-title":"An Bras Dermatol"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"e15","DOI":"10.1159\/000320891","volume":"118","author":"Dixon B.P.","year":"2011","unstructured":"Dixon B.P.; Hulbert J.C.; Bissler J.J.; Tuberous sclerosis complex renal disease. Nephron, Exp Nephrol 2011,118(1),e15-e20","journal-title":"Nephron, Exp Nephrol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1007\/s00467-014-3027-9","volume":"30","author":"De Waele L.","year":"2015","unstructured":"De Waele L.; Lagae L.; Mekahli D.; Tuberous sclerosis complex: The past and the future. Pediatr Nephrol 2015,30(10),1771-1780","journal-title":"Pediatr Nephrol"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1007\/s11547-015-0572-7","volume":"121","author":"Robert A.","year":"2016","unstructured":"Robert A.; Leroy V.; Riquet A.; Gogneaux L.; Boutry N.; Avni F.E.; Renal involvement in tuberous sclerosis complex with emphasis on cystic lesions. Radiol Med (Torino) 2016,121(5),402-408","journal-title":"Radiol Med (Torino)"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1056\/NEJMoa1205511","volume":"367","author":"Torres V.E.","year":"2012","unstructured":"Torres V.E.; Chapman A.B.; Devuyst O.; Tolvaptan in patients with autosomal dominant polycystic kidney disease. N Engl J Med 2012,367(25),2407-2418","journal-title":"N Engl J Med"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1056\/NEJMoa1710030","volume":"377","author":"Torres V.E.","year":"2017","unstructured":"Torres V.E.; Chapman A.B.; Devuyst O.; Tolvaptan in later-stage autosomal dominant polycystic kidney disease. N Engl J Med 2017,377(20),1930-1942","journal-title":"N Engl J Med"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1681\/ASN.2013101138","volume":"26","author":"Irazabal M.V.","year":"2015","unstructured":"Irazabal M.V.; Rangel L.J.; Bergstralh E.J.; Imaging classification of autosomal dominant polycystic kidney disease: A simple model for selecting patients for clinical trials. J Am Soc Nephrol 2015,26(1),160-172","journal-title":"J Am Soc Nephrol"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1093\/ndt\/12.9.1900","volume":"12","author":"Longa L.","year":"1997","unstructured":"Longa L.; Scolari F.; Brusco A.; A large TSC2 and PKD1 gene deletion is associated with renal and extrarenal signs of autosomal dominant polycystic kidney disease. Nephrol Dial Transplant 1997,12(9),1900-1907","journal-title":"Nephrol Dial Transplant"},{"key":"ref=16","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1159\/000059874","volume":"122","author":"Mancino C.","year":"1997","unstructured":"Mancino C.; Balducci A.; Tuberous sclerosis complex and early-onset autosomal dominant polycystic kidney disease as a \u2018contiguous gene\u2019 syndrome: Report of a case. Contrib Nephrol 1997,122,96-97","journal-title":"Contrib Nephrol"},{"key":"ref=17","first-page":"bcr2013200711","volume":"2013","author":"Dhakal M","year":"2013","unstructured":"Dhakal M; Dhakal OP; Bhandari D; Polycystic kidney disease and chronic renal failure in tuberous sclerosis. Case Rep 2013,2013(oct021),bcr2013200711","journal-title":"Case Rep"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1177\/1066896908319578","volume":"16","author":"Bisceglia M.","year":"2008","unstructured":"Bisceglia M.; Galliani C.; Carosi I.; Simeone A.; Ben-Dor D.; Tuberous sclerosis complex with polycystic kidney disease of the adult type: The TSC2\/ADPKD1 contiguous gene syndrome. Int J Surg Pathol 2008,16(4),375-385","journal-title":"Int J Surg Pathol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"bcr-2017-220766","DOI":"10.1136\/bcr-2017-220766","volume":"2017","author":"Santos S.F.","year":"2017","unstructured":"Santos S.F.; Francisco T.; Cordeiro A.I.; Lopes M.J.P.; Beyond polycystic kidney disease. BMJ Case Rep 2017,2017,bcr-2017-220766","journal-title":"BMJ Case Rep"},{"key":"ref=20","first-page":"351","volume":"58","author":"Culty T.","year":"2006","unstructured":"Culty T.; Molinie V.; Lebret T.; TSC2\/PKD1 contiguous gene syndrome in an adult. Minerva Urol Nefrol 2006,58(4),351-354","journal-title":"Minerva Urol Nefrol"},{"journal-title":"Classification of Typical ADPKD Calculator","key":"ref=21","unstructured":"Classification of Typical ADPKD Calculator Mayo Foundation and Medical Education and ResearchAvailable from:  Accessed on Apr 14, 2021."},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3389\/fped.2018.00065","volume":"6","author":"M&#xFC;ller R-U.","year":"2018","unstructured":"M&#xFC;ller R-U.; Benzing T.; Cystic kidney diseases from the adult nephrologist\u2019s point of view. Front Pediatr 2018,6,65","journal-title":"Front Pediatr"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1038\/sj.ki.5001853","volume":"70","author":"Rakowski S.K.","year":"2006","unstructured":"Rakowski S.K.; Winterkorn E.B.; Paul E.; Steele D.J.R.; Halpern E.F.; Thiele E.A.; Renal manifestations of tuberous sclerosis complex: Incidence, prognosis, and predictive factors. Kidney Int 2006,70(10),1777-1782","journal-title":"Kidney Int"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1086\/514888","volume":"61","author":"Sampson J.R.","year":"1997","unstructured":"Sampson J.R.; Maheshwar M.M.; Aspinwall R.; Renal cystic disease in tuberous sclerosis: Role of the polycystic kidney disease 1 gene. Am J Hum Genet 1997,61(4),843-851","journal-title":"Am J Hum Genet"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1093\/hmg\/ddn325","volume":"18","author":"Hartman T.R.","year":"2009","unstructured":"Hartman T.R.; Liu D.; Zilfou J.T.; The tuberous sclerosis proteins regulate formation of the primary cilium via a rapamycin-insensitive and polycystin 1-independent pathway. Hum Mol Genet 2009,18(1),151-163","journal-title":"Hum Mol Genet"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.1093\/hmg\/ddp149","volume":"18","author":"Bonnet C.S.","year":"2009","unstructured":"Bonnet C.S.; Aldred M.; von Ruhland C.; Harris R.; Sandford R.; Cheadle J.P.; Defects in cell polarity underlie TSC and ADPKD-associated cystogenesis. Hum Mol Genet 2009,18(12),2166-2176","journal-title":"Hum Mol Genet"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12881-015-0185-y","volume":"16","author":"Cabrera-L&#xF3;pez C.","year":"2015","unstructured":"Cabrera-L&#xF3;pez C.; Bullich G.; Mart&#xED; T.; Insight into response to mTOR inhibition when PKD1 and TSC2 are mutated. BMC Med Genet 2015,16(1),39","journal-title":"BMC Med Genet"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"e9239","DOI":"10.1371\/journal.pone.0009239","volume":"5","author":"Dere R.","year":"2010","unstructured":"Dere R.; Wilson P.D.; Sandford R.N.; Walker C.L.; Carboxy terminal tail of polycystin-1 regulates localization of TSC2 to repress mTOR. PLoS One 2010,5(2),e9239","journal-title":"PLoS One"}],"container-title":["Current Reviews in Clinical and Experimental Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/2772432817666220517162012","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/204934\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/2772432817666220517162012","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T10:52:36Z","timestamp":1683197556000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/204934\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/2772432817666220517162012","relation":{},"ISSN":["2772-4328"],"issn-type":[{"type":"print","value":"2772-4328"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2021-08-31","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-02-04","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-02-17","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-03-08","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}